Targeting the HBV-Macrophage-Stellate cell axis to treat HBV-induced Liver Diseases- Lishan Su

HEP DART 2017

Universal access to all essential medicines – What can be done?- Andrew Hill, MD

INTEREST 2017

Natural History of HCV Infection | Krzysztof Simon, MD, PhD

Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015

Inhaled Therapy for TB - Edward Nardell, MD

International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2014

Debate: Statin Preventative Therapy to Reduce Cardiovascular Risks in Women Living with HIV - Community Representative: Against the Proposition - Magdalena Ankiersztejn-Bartczak, PhD

15th International Workshop on Women & HIV 2025

How many adolescents do we actually lose along the HIV treatment cascade?: Accounting for aging up in adolescent continuity of treatment

International Workshop on HIV & Adolescence 2021

Vaccine Hesitancy in the Era of Emerging Diseases | Jeremy K. Ward

AIDSImpact 2021 | Webinar Series

Global elimination of hepatitis C: meeting the World Health Organization’s 2030 goal

International Viral Hepatitis Elimination Meeting (IVHEM) 2020

Optimizing HIV Treatment among Children in Mozambique

INTEREST 2020

Intensified campaign to return people lost to follow-up to antiretroviral therapy: A success story from John F Kennedy Medical Center (JFKMC) Monrovia, Liberia

INTEREST 2020